colchicine has been researched along with Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, ML; Finsterer, J; Oliveira, LF; Rodrigues, LD; Scorza, CA; Scorza, FA; Tufik, S | 1 |
| Feng, J; Jiang, H; Nakaso, K; Ren, Y; Yang, F | 1 |
| Arias-Carrión, O; Salama, M | 1 |
| Arias-Carrión, O; El-Gamal, M; Ellaithy, A; Helmy, B; Mohamed, M; Salama, M; Sheashaa, H; Sobh, M; Tantawy, D | 1 |
| Feng, J; Ren, Y; Zhao, J | 1 |
| Feng, J; Jiang, H; Jiang, Q; Liu, W; Ren, Y | 1 |
| Feng, J; Ren, Y | 1 |
| Gillman, MA; Sandyk, R | 1 |
| Hirano, A; Terry, RD; Wiśniewski, H | 1 |
9 other study(ies) available for colchicine and Parkinson Disease
| Article | Year |
|---|---|
We never speak about sudden unexpected death in Parkinson's disease.
Topics: Colchicine; Coronary Artery Disease; Death, Sudden; Humans; Parkinson Disease; Stroke | 2020 |
Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation.
Topics: Adult; B-Lymphocytes; Cell Line; Colchicine; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Fibroblasts; Humans; Insecticides; Male; Mesencephalon; Middle Aged; Mutation; Neurons; Nocodazole; Parkinson Disease; Protein Structure, Tertiary; Rotenone; Tubulin Modulators; Ubiquitin-Protein Ligases | 2009 |
Colchicine as a promising drug for Parkinson's disease.
Topics: Colchicine; Humans; Parkinson Disease | 2011 |
Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Colchicine; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Dyskinesias; Injections, Intraperitoneal; Locomotion; Nerve Tissue Proteins; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tremor; Tubulin Modulators; Tyrosine 3-Monooxygenase | 2012 |
Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
Topics: Animals; Antibody Specificity; Cells, Cultured; Colchicine; Dimerization; Fibroblasts; Humans; Kidney; Ligases; Male; Mice; Microtubule-Associated Proteins; Microtubules; Mutation; Nerve Tissue Proteins; Neuroblastoma; Neurons; Paclitaxel; Parkinson Disease; Protein Binding; Rats; Rats, Sprague-Dawley; Tubulin; Ubiquitin-Protein Ligases; Ubiquitins | 2003 |
Selective vulnerability of dopaminergic neurons to microtubule depolymerization.
Topics: Cell Death; Colchicine; Cytosol; Dopamine; Humans; Microtubules; Nerve Degeneration; Nocodazole; Oxidative Stress; Paclitaxel; Parkinson Disease; Polymers; Receptors, Dopamine; Rotenone; Substantia Nigra; Uncoupling Agents | 2005 |
Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism.
Topics: Amobarbital; Animals; Cell Death; Cells, Cultured; Colchicine; Electron Transport Complex I; Mesencephalon; Microtubules; Neurons; Parkinson Disease; Rats; Rotenone; Serotonin; Ubiquitin-Protein Ligases | 2007 |
Colchicine ameliorates constipation in Parkinson's disease.
Topics: Colchicine; Constipation; Humans; Parkinson Disease | 1984 |
Neurofibrillary pathology.
Topics: Aluminum; Amyotrophic Lateral Sclerosis; Animals; Autopsy; Biopsy; Brain; Brain Diseases; Central Nervous System Diseases; Colchicine; Dementia; Encephalitis, Arbovirus; Humans; Microscopy, Electron; Middle Aged; Neurofibrils; Parkinson Disease; Podophyllin; Vinblastine; Vincristine | 1970 |